Literature DB >> 19559651

Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors.

Arthur M Dannenberg1.   

Abstract

To control tuberculosis in the world today an additional approach would be most welcomed. Preventing (or reducing) pulmonary cavity formation is one such approach that has been almost completely neglected. Pulmonary cavity formation and the extracellular growth of tubercle bacilli in cavities cause bronchial spread of the disease in adult patients and spread of the bacillus to the environment where they infect other people. Therefore, cavity formation perpetuates tuberculosis in mankind. If no cavities form, the patient is much less infectious. Also, cavity formation often allows the tubercle bacillus to multiply (extracellularly) to tremendous numbers. Therefore, in humans almost all multidrug-resistant tubercle bacilli develop in cavities. This communication reviews the literature on liquefaction and cavity formation, and lists some of the responsible hydrolytic enzymes. It also describes a simple method to identify inhibitory pharmaceuticals, i.e., to observe their effect on the liquefaction and ulceration of skin lesions produced in rabbits by ascending concentrations of live or dead tubercle bacilli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559651     DOI: 10.1016/j.tube.2009.05.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  15 in total

1.  Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Authors:  Amador Goodridge; Carla Cueva; Maureen Lahiff; Grace Muzanye; John L Johnson; Payam Nahid; Lee W Riley
Journal:  Tuberculosis (Edinb)       Date:  2012-03-10       Impact factor: 3.131

Review 2.  Animal Models for Tuberculosis in Translational and Precision Medicine.

Authors:  Lingjun Zhan; Jun Tang; Mengmeng Sun; Chuan Qin
Journal:  Front Microbiol       Date:  2017-05-04       Impact factor: 5.640

3.  Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice.

Authors:  Stephen T Reece; Christoph Loddenkemper; David J Askew; Ulrike Zedler; Sandra Schommer-Leitner; Maik Stein; Fayaz Ahmad Mir; Anca Dorhoi; Hans-Joachim Mollenkopf; Gary A Silverman; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

Review 4.  Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.

Authors:  Anca Dorhoi; Stefan H E Kaufmann
Journal:  Semin Immunopathol       Date:  2015-10-05       Impact factor: 9.623

5.  Evaluation of mycobacterial virulence using rabbit skin liquefaction model.

Authors:  Guoping Zhang; Bingdong Zhu; Wanliang Shi; Mingzhu Wang; Zejiao Da; Ying Zhang
Journal:  Virulence       Date:  2010 May-Jun       Impact factor: 5.882

6.  Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.

Authors:  Laura E Via; Dan Schimel; Danielle M Weiner; Veronique Dartois; Emmanuel Dayao; Ying Cai; Young-Soon Yoon; Matthew R Dreher; Robin J Kastenmayer; Charles M Laymon; J Eoin Carny; Joanne L Flynn; Peter Herscovitch; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

7.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 8.  Perspectives on clinical and preclinical testing of new tuberculosis vaccines.

Authors:  Arthur M Dannenberg
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

9.  Diverse Cavity Types and Evidence that Mechanical Action on the Necrotic Granuloma Drives Tuberculous Cavitation.

Authors:  Elizabeth A Ihms; Michael E Urbanowski; William R Bishai
Journal:  Am J Pathol       Date:  2018-05-23       Impact factor: 4.307

10.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

Authors:  Paul Elkington; Takayuki Shiomi; Ronan Breen; Robert K Nuttall; Cesar Augusto Ugarte-Gil; Naomi F Walker; Luísa Saraiva; Bernadette Pedersen; Francesco Mauri; Marc Lipman; Dylan R Edwards; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.